158 related articles for article (PubMed ID: 10666179)
1. Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli.
Minnema MC; Chang AC; Jansen PM; Lubbers YT; Pratt BM; Whittaker BG; Taylor FB; Hack CE; Friedman B
Blood; 2000 Feb; 95(4):1117-23. PubMed ID: 10666179
[TBL] [Abstract][Full Text] [Related]
2. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli.
Taylor FB; Chang AC; Peer G; Li A; Ezban M; Hedner U
Blood; 1998 Mar; 91(5):1609-15. PubMed ID: 9473226
[TBL] [Abstract][Full Text] [Related]
3. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock.
Carr C; Bild GS; Chang AC; Peer GT; Palmier MO; Frazier RB; Gustafson ME; Wun TC; Creasey AA; Hinshaw LB
Circ Shock; 1994 Nov; 44(3):126-37. PubMed ID: 7600636
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons.
Taylor FB; Emerson TE; Jordan R; Chang AK; Blick KE
Circ Shock; 1988 Nov; 26(3):227-35. PubMed ID: 3061681
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human antithrombin III: rhATIII.
Drugs R D; 2004; 5(2):110-2. PubMed ID: 15293873
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli.
Creasey AA; Stevens P; Kenney J; Allison AC; Warren K; Catlett R; Hinshaw L; Taylor FB
Circ Shock; 1991 Feb; 33(2):84-91. PubMed ID: 2049816
[TBL] [Abstract][Full Text] [Related]
8. Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma.
Jansen PM; van der Pouw Kraan TC; de Jong IW; van Mierlo G; Wijdenes J; Chang AA; Aarden LA; Taylor FB; Hack CE
Blood; 1996 Jun; 87(12):5144-51. PubMed ID: 8652827
[TBL] [Abstract][Full Text] [Related]
9. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia.
Emerson TE; Fournel MA; Redens TB; Taylor FB
Am J Med; 1989 Sep; 87(3B):27S-33S. PubMed ID: 2679067
[TBL] [Abstract][Full Text] [Related]
11. C4b-binding protein exacerbates the host response to Escherichia coli.
Taylor F; Chang A; Ferrell G; Mather T; Catlett R; Blick K; Esmon CT
Blood; 1991 Jul; 78(2):357-63. PubMed ID: 1829967
[TBL] [Abstract][Full Text] [Related]
12. Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons.
Welty-Wolf KE; Carraway MS; Miller DL; Ortel TL; Ezban M; Ghio AJ; Idell S; Piantadosi CA
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1988-96. PubMed ID: 11734456
[TBL] [Abstract][Full Text] [Related]
13. Recombinant activated protein C attenuates endothelial injury and inhibits procoagulant microparticles release in baboon heatstroke.
Bouchama A; Kunzelmann C; Dehbi M; Kwaasi A; Eldali A; Zobairi F; Freyssinet JM; de Prost D
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1318-25. PubMed ID: 18451327
[TBL] [Abstract][Full Text] [Related]
14. PEG-BP-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock.
Espat NJ; Cendan JC; Beierle EA; Auffenberg TA; Rosenberg J; Russell D; Kenney JS; Fischer E; Montegut W; Lowry SF
J Surg Res; 1995 Jul; 59(1):153-8. PubMed ID: 7630120
[TBL] [Abstract][Full Text] [Related]
15. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants.
Taylor FB
Crit Care Med; 2001 Jul; 29(7 Suppl):S78-89. PubMed ID: 11445739
[TBL] [Abstract][Full Text] [Related]
16. Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia.
Jansen PM; Boermeester MA; Fischer E; de Jong IW; van der Poll T; Moldawer LL; Hack CE; Lowry SF
Blood; 1995 Aug; 86(3):1027-34. PubMed ID: 7620156
[TBL] [Abstract][Full Text] [Related]
17. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
18. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli.
de Boer JP; Creasy AA; Chang A; Roem D; Brouwer MC; Eerenberg AJ; Hack CE; Taylor FB
Circ Shock; 1993 Jan; 39(1):59-67. PubMed ID: 7683256
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase.
Jansen PM; Pixley RA; Brouwer M; de Jong IW; Chang AC; Hack CE; Taylor FB; Colman RW
Blood; 1996 Mar; 87(6):2337-44. PubMed ID: 8630396
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
Creasey AA; Chang AC; Feigen L; Wün TC; Taylor FB; Hinshaw LB
J Clin Invest; 1993 Jun; 91(6):2850-60. PubMed ID: 8514893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
